Pulse Biosciences (FRA:6L8) E10: €-1.54 (As of Mar. 2026)


FRA:6L8 Pulse Biosciences Inc FRA:6L8
31 GF Score
Price €23.60
! 3 Warning Signs
View Full Analysis

What is Pulse Biosciences E10?

Pulse Biosciences FRA:6L8 -3.28% 31 E10 is €-1.54 as of Mar. 2026. GuruFocus rates FRA:6L8 with a GF Score™ of 31/100. The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Pulse Biosciences's adjusted earnings per share data for the three months ended in Mar. 2026 was €-0.234. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-1.54 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-07-11), Pulse Biosciences's current stock price is €23.60. Pulse Biosciences's E10 for the quarter that ended in Mar. 2026 was €-1.54. Pulse Biosciences's Shiller PE Ratio of today is .


Pulse Biosciences  (FRA:6L8) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Pulse Biosciences E10 Related Terms


Pulse Biosciences E10 Historical Data

* Premium members only.

The historical data trend for Pulse Biosciences's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pulse Biosciences E10 Chart

Pulse Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -1.76 -1.63

Pulse Biosciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.73 -1.57 -1.60 -1.63 -1.54

FRA:6L8 vs LMAT, XRAY, KMTS: E10 Comparison

For the Medical Instruments & Supplies subindustry, Pulse Biosciences's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pulse Biosciences Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Pulse Biosciences's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Pulse Biosciences's Shiller PE Ratio falls into.


FRA:6L8
31GF Score
Pulse Biosciences Inc FRA:6L8
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pulse Biosciences E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Pulse Biosciences's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.234/330.2130*330.2130
=-0.234

Current CPI (Mar. 2026) = 330.2130.

Pulse Biosciences Quarterly Data

per share eps CPI Adj_EPS
201606 -0.201 241.018 -0.275
201609 -0.184 241.428 -0.252
201612 -0.196 241.432 -0.268
201703 -0.211 243.801 -0.286
201706 -0.376 244.955 -0.507
201709 -0.429 246.819 -0.574
201712 -0.440 246.524 -0.589
201803 -0.407 249.554 -0.539
201806 -0.455 251.989 -0.596
201809 -0.539 252.439 -0.705
201812 -0.441 251.233 -0.580
201903 -0.426 254.202 -0.553
201906 -0.479 256.143 -0.618
201909 -0.509 256.759 -0.655
201912 -0.584 256.974 -0.750
202003 -0.507 258.115 -0.649
202006 -0.463 257.797 -0.593
202009 -0.426 260.280 -0.540
202012 -0.436 260.474 -0.553
202103 -0.586 264.877 -0.731
202106 -0.473 271.696 -0.575
202109 -0.401 274.310 -0.483
202112 -0.453 278.802 -0.537
202203 -0.518 287.504 -0.595
202206 -0.409 296.311 -0.456
202209 -0.487 296.808 -0.542
202212 -0.232 296.797 -0.258
202303 -0.239 301.836 -0.261
202306 -0.203 305.109 -0.220
202309 -0.178 307.789 -0.191
202312 -0.193 306.746 -0.208
202403 -0.166 312.332 -0.176
202406 -0.186 314.175 -0.195
202409 -0.189 315.301 -0.198
202412 -0.296 315.605 -0.310
202503 -0.231 319.799 -0.239
202506 -0.243 322.561 -0.249
202509 -0.247 324.800 -0.251
202512 -0.222 324.054 -0.226
202603 -0.234 330.213 -0.234

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €-1.54 mean?
Pulse Biosciences (FRA:6L8) has a E10 of €-1.54 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Pulse Biosciences and its competitors.
Is Pulse Biosciences' E10 too high?
Pulse Biosciences' current E10 is €-1.54. Overall, Pulse Biosciences has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Pulse Biosciences' E10 compare to LMAT and XRAY?
Pulse Biosciences' E10 of €-1.54 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Devices & Instruments company?
A good E10 depends on the Medical Devices & Instruments industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Pulse Biosciences and its competitors. Pulse Biosciences's current E10 is €-1.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pulse Biosciences stock overvalued right now?
Pulse Biosciences (FRA:6L8) has a current E10 of €-1.54. The current E10 is €-1.54. Pulse Biosciences' overall GF Score™ is 31/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Pulse Biosciences (FRA:6L8), the current E10 is €-1.54 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pulse Biosciences Business Description

Other Exchanges PLSE:USA
Address 601 Brickell Key Drive, Suite 1080, Miami, FL, USA, 33131
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
31GF Score

Get the complete analysis for FRA:6L8

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€23.60
Price